PRS-080

· Pieris Pharmaceuticals GmbH

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PRS-080, covering 2015-08-10 to 2019-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients [Phase 1, Phase 2]